Pfizer Opens Radiation Biology R&D Center in Wuhan

Pfizer announced that its new R&D center in Wuhan is up and running. Previously reported as intellectual support for Phase I through IV clinical studies, Pfizer added that the facility’s particular focus will be radiation biology. The center will work on trials from around the world. Currently, the Wuhan center has 40 employees, a number that will grow to 200 by 2012. More details.... Stock Symbol: (NYSE: PFE)